Table 1:

Clinical and demographic characteristics of the patients and control subjects^*

	FE Group		Chronic Group		Combined Group
	FE Patients (n = 12)	Controls (n = 14)	Chronic Patients (n = 16)	Controls (n = 14)	All Patients (n = 28)	All Controls (n = 28)
Age (y)	25.50 ± 5.76	25.16 ± 5.35	29.31 ± 11.41	28.93 ± 10.24	27.65 ± 9.46	27.32 ± 8.58
Male/Female	8/4	9/5	11/5	9/5	19/9	18/10
Education (y)	10.33 ± 4.47	10.33 ± 3.89	11.00 ± 3.65	11.00 ± 3.40	10.71 ± 3.96	10.71 ± 3.56
Age at onset (y)	24.83 ± 5.30		22.37 ± 8.72		23.35 ± 7.13
No. of hospitalizations	–		4.30 ± 3.90		–
DUP (months)	11.20 ± 10.20		–		–
Duration of illness (months)	–		83.25 ± 68.65		–
Psychopathology scores
BPRS	58.75 ± 8.60		67.56 ± 11.18		63.92 ± 10.96
SANS	40.00 ± 17.62		50.37 ± 26.93		45.92 ± 23.60
SAPS	36.58 ± 17.11		43.87 ± 15.89		40.75 ± 16.52

Note:—FE indicates first-episode; –, data not available.; DUP, duration of untreated psychosis; BPRS, Brief Psychiatric Rating Scale; SANS, Scale for the Assessment of Negative Symptoms; SAPS, Scale for the Assessment of Positive Symptoms.

^*Data are given as mean ± SDs except where indicated.